Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Outstanding (Weighted Average) (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Shares Outstanding (Weighted Average) data on record, last reported at $22.5 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 25.68% year-over-year to $22.5 million; the TTM value through Dec 2025 reached $22.5 million, up 25.68%, while the annual FY2025 figure was $22.5 million, 25.68% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $22.5 million in Q4 2025 per PRAX's latest filing, up from $21.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $45.6 million in Q3 2022 and bottomed at $3.1 million in Q4 2022.
  • Average Shares Outstanding (Weighted Average) over 4 years is $19.5 million, with a median of $17.6 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 92.21% in 2023, then surged 299.34% in 2024.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $3.1 million in 2022, then surged by 114.58% to $6.6 million in 2023, then surged by 171.55% to $17.9 million in 2024, then rose by 25.68% to $22.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $22.5 million in Q4 2025, $21.5 million in Q3 2025, and $21.3 million in Q2 2025.